Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Mitsuhiro Nakamura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6406-2097; OpenAlex author ID A5091878958. Sources: OpenAlex.

Their work

Papers
18 (first author 8, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2012: 3 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: 4 papers · 2024: none · 2025: 2 papers

Papers 18

  1. Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patien… Co-author DOI 10.1002/cam4.70648↗
  2. Dosimetric performance of cone beam CT-guided adaptive carbon-ion radiotherapy with daily replanning for pancreatic cancer. Last author DOI 10.1016/j.ejmp.2025.104991↗
  3. Potential utility of cone-beam CT-guided adaptive radiotherapy under end-exhalation breath-hold conditions for pancreatic cancer. First author DOI 10.1002/acm2.13827↗
  4. Assessing target localization accuracy across different soft-tissue matching protocols using end-exhalation breath-hold cone-beam computed tomography in patien… First author DOI 10.1093/jrr/rrad048↗
  5. Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced … Co-author DOI 10.1186/s13014-023-02288-3↗
  6. Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for local… Co-author DOI 10.1186/s13014-023-02321-5↗
  7. Statistical deformation reconstruction using multi-organ shape features for pancreatic cancer localization. First author DOI 10.1016/j.media.2020.101829↗
  8. Statistical shape model-based planning organ-at-risk volume: application to pancreatic cancer patients. Co-author DOI 10.1088/1361-6560/abcd1b↗
  9. Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer pati… First author DOI 10.1002/acm2.12883↗
  10. Positional repeatability and variation in internal and external markers during volumetric-modulated arc therapy under end-exhalation breath-hold conditions for… First author DOI 10.1093/jrr/rraa054↗
  11. Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases. First author DOI 10.1002/acm2.12720↗
  12. Accumulation of the delivered treatment dose in volumetric modulated arc therapy with breath-hold for pancreatic cancer patients based on daily cone beam compu… First author DOI 10.1002/mp.13566↗
  13. Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1038/s41598-018-35402-7↗
  14. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose… Co-author DOI 10.1118/1.4773033↗
  15. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a… First author DOI 10.1120/jacmp.v14i5.4252↗
  16. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2011.01.050↗
  17. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer pat… Co-author DOI 10.1016/j.ijrobp.2011.12.026↗
  18. Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Co-author DOI 10.1118/1.3668314↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Mizowaki · 16 shared papers, 2012–2025 · strength 2.38
  2. Michio Yoshimura · 11 shared papers, 2018–2025 · strength 1.99
  3. Ryo Ashida · 7 shared papers, 2019–2023 · strength 1.16
  4. Takahiro Iwai · 3 shared papers, 2023–2025 · strength 0.68
  5. Ayaka Ogawa · 3 shared papers, 2023 · strength 0.65
  6. Masahiro Hiraoka · 7 shared papers, 2012–2025 · strength 0.49
  7. Makoto Sasaki · 3 shared papers, 2019–2023 · strength 0.44
  8. Megumi Nakao · 2 shared papers, 2021 · strength 0.34
  9. Lukas Fabrizio Klassen · 1 shared paper, 2025 · strength 0.27
  10. Katsuyuki Karasawa · 1 shared paper, 2025 · strength 0.25
  11. Akira Nakamura · 6 shared papers, 2012–2018 · strength 0.24
  12. Naozo Sugimoto · 2 shared papers, 2019–2020 · strength 0.22
  13. Tetsuya Matsuda · 1 shared paper, 2021 · strength 0.19
  14. Yökö Gotö · 2 shared papers, 2018–2019 · strength 0.17
  15. Keiko Shibuya · 5 shared papers, 2012–2013 · strength 0.17
  16. Marc Ziegler · 1 shared paper, 2019 · strength 0.11
  17. Takahiro Kishi · 1 shared paper, 2018 · strength 0.07
  18. Teruki Teshima · 1 shared paper, 2013 · strength 0.03
  19. Toru Takakura · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.